Jayasree Iyer: Generics and bio similars are key in achieving access to medicines for all.
Quoting Jayasree Iyer, CEO of Access to Medicine Foundation, on LinkedIn:
”Generics and bio similars are key in achieving access to medicines for all. Nonetheless, they remain out of reach for most people in LMICs, especially for the most vulnerable groups. Leading generic manufacturers are key players in addressing this access2meds issue.
The Access to Medicine Foundation’s Generic & Biosimilar Medicine Programme’s first report analyses the efforts of five major players of the generic industry in expanding access to medicines in LMICs.
The key findings of our report reveal untapped potential in areas such as product registration expansion, refining access strategies, and fostering local manufacturing to ensure a consistent supply of essential medications.
Building on these results, the report also provides guidance to these companies, including valuable insights and clear strategies to fulfill their potential and make a difference in the lives of people lacking access in LMICs. ”
For the report click here.
Source: Jayasree Iyer/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023